Immune reconstitution syndrome associated with parvovirus B19-induced pure red cell aplasia during highly active antiretroviral therapy.
Persistent parvovirus B19 (B19) manifested as chronic pure red cell aplasia (PRCA) has been described in HIV patients. Immune reconstitution syndrome (IRS) is an immune response to an occult opportunistic pathogen or tumor antigen, usually occurs after antiretroviral treatment. We describe the first case of IRS associated with B19-induced PRCA during highly active antiretroviral therapy.
Intalapaporn
Poj
P
Division of Infectious Diseases, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.
Poovorawan
Yong
Y
Suankratay
Chusana
C
D019380:Anti-HIV Agents / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D005260:Female; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D008875:Middle Aged; D010322:Parvoviridae Infections / Q000150:complications*; D016732:Parvovirus B19, Human / Q000302:isolation & purification*; D012010:Red-Cell Aplasia, Pure / Q000209:etiology*
D019380:Anti-HIV Agents